Mike is currently Chief Scientific Officer at DiaCarta, Inc. where he manages the company’s scientific and strategic direction in molecular diagnostics for oncology and infectious disease personalized diagnostics markets, most notably the development of branched DNA (bDNA) signal amplification and a novel somatic gene mutation Real-Time PCR based assay technology called QClampTM for applications in the diagnosis of cancer and infectious diseases and the rapid detection of cancer 'driver' and drug resistance genetic variations. Mike was previously a Founder of Odyssey Thera Inc., a privately held company that commercialized a proprietary fluorescent live cell-based assay and diagnostic imaging technology for the application in target validation and drug discovery. Mike was the Director of New Technology at Roche Diagnostics (Roche acquired Boehringer Mannheim Corporation in May 1997 for $11B). Prior to the acquisition by Roche, he was Director of New Technology at Boehringer Mannheim. He was also the Director of New Technology at Microgenics Corporation, in Concord, California. He was a pioneer and lead scientist and inventor of the electrochemiluminescence (ECL) assay technology and also developed catalytic antibodies at IGEN, Inc. The ECL technology is the basis of Roche Diagnostics automated ‘in-vitro’ diagnostics immunoassay platform: ‘ElecSys’. Mike has held several other R & D senior management positions at Integrated Genetics Inc., Medisense and Celltech PLC, in the UK. Mike has published many research papers in leading scientific journals and holds over 30 patents and patent-pending applications. He received his Ph.D. in medicinal organic chemistry from Loughborough University, Loughborough, UK and Ph.D. from the University of Nottingham, Nottingham, UK.
Assay Development, Biopharmaceticals, Oncology, Medicinal organic chemistry, Drug Discovery, Genomics, Molecular Biology, Biochemistry
Desineni “Subbaram” Naidu received MTech and PhD (1979) degrees in Electrical Engineering (with specialization in Control Systems Engineering), from Indian Institute of Technology (IIT), Kharagpur, INDIA. Dr. Naidu taught, visited and/or conducted research at IIT; National Research Council (NRC) Senior Research Associate at Guidance and Control Division at NASA Langley Research Center, Hampton, VA, USA (1985-90); Old Domain University, Norfolk, VA, USA (1987-90); as Professor, Associate Dean and Director, School of Engineering at Idaho State University and Measurement and Control Engineering Research Center, Pocatello, Idaho, USA (1990-2014); National Research Council (NRC) Senior Research Associate at Center of Excellence in Advanced Flight Research at United States (US) Air Force Research Laboratory, Wright Patterson Air Force Base (WPAFB), Ohio, USA (1998-99); Visiting Research Fellow at Center of Excellence for Ships and Ocean Structures at Norwegian University of Science and Technology, Trondheim, NORWAY (2014); Academic Guest at Measurement and Control Laboratory at Swiss Federal Institute of Technology, Zurich, SWITZERLAND (2015); Visiting Professor at Nantong University, Nantong, CHINA (2007); Jiangsu College of Information Technology, Jiangsu, CHINA (2007); Visiting Research Professor at the University of Western Australia in Perth, and Center for Industrial and Applied Mathematics at the University of South Australia, Adelaide, AUSTRALIA (2008); Visiting Professor at the Center for Applied and Interdisciplinary Mathematics at East China Normal University, Shanghai, CHINA (2011); Visiting Professor at the Institute of Systems Science, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, CHINA (2011); Shanghai Jiao-Tong University, Shanghai, CHINA (2011), Nizhny Novgorod and Moscow State University, Moscow, RUSSIA (2012) and Satish Dhawan Endowed Visiting Professor at Indian Inst. of Science (IISc), Bengaluru, INDIA (2017). Since August 2014, Professor Naidu has been with University of Minnesota Duluth as Minnesota Power Jack Rowe Endowed Chair and Professor of Electrical Engineering. Professor Naidu received twice the Senior National Research Council (NRC) Associateship award from the US National Academy of Sciences (NAS), and is an elected (1995) (now Life) Fellow of the Institute of Electrical and Electronic Engineers (IEEE) and an elected (2003) Fellow of the World Innovation Foundation, UK.
Dr. Sergey Suchkov, MD, Ph.D. Professor in Immunology & Medicine. Personal: Born 11 January 1957, Astrakhan, Russia.Honors: Secretary-General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; European Association for Predictive, Preventive and Personalized Medicine, Brussels; American Association for Research in Vision and Ophthalmology; International Society for Eye Research; EPMA Journal, Personalized Medicine Universe, Open J.Autoimmunity and American J.Cardiovascular Res. Editorial Boards; All-Union (from 1992 - Russian) Biochemical Society; All-Union (from 1992 - Russian) Immunological Society.
Cancer Immunology, Preventive and Personalized Medicine,Immunology, Medicine, Pathology, Clinical Immunology,Biomedical Sciences
Ye Hua, MD, MPH is the founder and CEO of BioNova Pharmaceuticals, a start-up biotech company that is focused on new drug development and regulatory registration to fill the gap of unmet medical needs in oncology and other diseases. Prior to building up BioNova, he was Senior VP, Head of Clinical Development and Regulatory Affairs at Hutchison MediPharm, a leading R&D company in oncology and autoimmune diseases. Managing the clinical and regulatory organization, Dr. Hua is responsible for advancing clinical development pipeline and registering new drugs in China and ex-China. Under his leadership, the clinical development programs have grown from 5 small molecules in 7 Phase 1 oncology clinical trials to 8 small molecules in over 30 Phase 1-3 clinical trials in oncology and immunology in China, Australia, and the USA. Most recently, Dr. Hua led fruquintinib NDA submission in mCRC indication via MAH policy and received NMPA approval. Native from Shanghai, Dr. Hua graduated from Fudan University Shanghai Medical College in 1992. He worked as a cancer epidemiologist at Shanghai Cancer Institute between 1992 and 1996, and then went to McGill University in Montreal Canada to pursue a Master Degree in cancer epidemiology. Dr. Hua is a senior clinical research physician who has over seventeen years’ global clinical development and new drug registration experience in the pharmaceutical industry. He started his career in the pharmaceutical industry as a biostatistician at Pharmacia & Upjohn in 1999, and worked through the rank in biostatistics. His most significant achievement being the statistical team leader for the pivotal Phase 3 RA registration trial of Humira that won regulatory approval in the US and EU. Often contributed to clinical programs beyond his role in statistics, Dr. Hua was well recognized and greatly appreciated by cross-functional development teams. In 2004, one year after joining Novartis, Dr. Hua successfully switched career track back to clinical. Being a medical monitor, he led a number of global Phase II/III registration trials in osteoarthritis, osteoporosis, infectious diseases, oncology and hematology disease areas. As clinical project leader, Dr. Hua contributed to the regulatory approval and life-cycle management for Reclast/Aclasta, Prexige, Zometa, Femara, Proleukin and Cardioxane in the US and EU. His last job in the US was Senior Director, Global Clinical Development, Celgene Corporation where he led several global clinical teams for Revlimid and Pomalyst NDA/sNDA in multiple myeloma indication, and eventually obtained regulatory approval in the US and EU. In addition, he led clinical subteam executed registration trials for Revlimid and Pomalyst in China, and successfully obtained Revlimid regulatory approval in multiple myeloma indication.
Professor Dr. Luisa Maria Arvide Cambra, Spanish is now Professor with Chair at the University of Almería (Spain) and she was Assistant Professor and Associate Professor at the University of Granada from 1979 on. Thirty-nine years of the teaching and researching experience. She is the Director of Research Group HUM113-Estudios Filológicos from Program of Research of Andalusian Government, where she has managed and directed several academic and scientific contracts and research projects, as well as a Member of Athens Institute for Education & Research (ATINER) in Greece, The Academic Genesis Platform (UAGP) in UK&Turkey and Experts of Academic Excellence Research Centre (EAERC) in Jordan; etc. She is the author of many works on several aspects of Arabic science and literature in the Middle Ages, as well as Arabic language and linguistics. She has also participated in different prestigious international scientific Conferences. She has visited many universities and academic institutions of Europe, the United States and Arab countries in order to teach and research. Among her works, we have the study and the translation to Spanish of some treatises of Kitab al-tasrif´s Al-Zahrawi, Ibn Qutayba´s texts, Maqamas of Al-Hariri, The Sicilian Questions of Ibn Sab´in, etcetera. She has published 11 books and over 90 articles and papers in prestigious international journals and proceedings.
Medieval Arabic Science. Humanities. Arabic Philology
Magnus S Magnusson, Research Professor. Ph.D. in 1983, University of Copenhagen. Author of the T-pattern model and the corresponding detection algorithms in the T-pattern detection and Analysis software THEMETM (PatternVision.com). He has focused on real-time organisation of behavior, co-directed DNA analysis, published numerous papers and given invited talks and keynotes at universities in Europe, USA and Japan and at international conferences in ethology, psychology, neuroscience, mathematical sciences, science of religion, proteomics and mass spectrometry. Deputy Director 1983-1988 in the Museum of Mankind, National Museum of Natural History, Paris. Repeatedly invited Professor in psychology and ethology (the biology of behavior) at the University of Paris, V, VIII and XIII. Since 1991, Founder and Director of the Human Behavior Laboratory (hbl.hi.is), University of Iceland. He works in collaboration between now 32 universities on Methodology for the Analysis of Social Interaction (MASI) initiated in 1995 at the Sorbonne, Paris based on “Magnusson’s analytical model
Jurgen received his MD from the University of Würzburg and completed his habilitation thesis on dietary fiber at the Gutenberg University Mainz. His primary career focus has been on internal medicine, gastroenterology, endocrinology and diabetology and nutritional medicine. He led the Institute of Physiology and Biochemistry of Nutrition of the MRI and has won several scientific awards. He works for the Clinical Research Center Kiel and is the professor for internal medicine at the University Medicine Mainz.
Enzyme biotechnology, Pro- and prebiotics; immunity, metabolic syndrome, mineral metabolism, Microbiology
Pr. Lingai LUO received her Ph.D. degree (1991) from National Polytechnic Institute of Lorraine (INPL), Nancy, France. She is Research Director of French National Center for Scientific Research (CNRS) and works at Laboratory of Thermal and Energy science at Nantes (LTEN). Pr. Luo is the author of 2 books and over 110 journal articles. She was the head of LOCIE Laboratory of CNRS and University of Savoie, the co-founder and coordinator of Sino-French Collaboratory for Environmental and Process Engineering and the head of its successor Sino-French Laboratory for Sustainable Energy of French CNRS and Chinese Academy of Sciences. She is serving as subject editor of Energy Journal and as associated editor of three others journals.
Recycling and thermal waste recovery, solar systems, heat recovery, Environmental Biotechnology
Jaleel Kareem Ahmed is a Professor of physical chemistry in the college of Materials Engineering, Babylon University, Iraq. He was the Dean of the Institute of Foundry and Hammering (2002-2013). He has his expertise in Iron and Steel Industry. He completed his Ph.D. from Baghdad University and Martin Luther / Germany. He used red beet juice as a scavenger for poisonous heavy metal ions and anticancer and detoxification of urea and uric acid from blood via urine system thus it helps kidney work. He has registered 8 patents with 40 published papers and 3 books. He is a reviewer in Jon Wily and Sons since 2016 USA and Editorial Board Member of Science publishing Group 2015 USA and a member in Encyclopedia of Chemistry Scientists 2012. In 2013 he was awarded Scientists Medal from Iraqi Government for my research "Using Chlorophyll as Gamma ray absorbent to protect Iraqi children from cancer ". In 2014 he became a member in Who is Who network. In 2018 Marquis Wh'o is Wh'o has selected him for their official 2018 Albert Nelson Marquis Lifetime Achievement Award in America. Since 2016 I took a part with quality Star (QS) Global Academic Survey (QS World University Rankings USA). In 2018 he was awarded an honor certificate from International Human Rights for my researches activity.
Biopolymers, Cancer studies, Chemistry and Polymeric chemistry
Francisco was born in Mexico City, is an Experimental Biologist from the Metropolitan Autonomous University, In 2014 made a research stay at the Institute of Biotechnology (IBT-UNAM) in the laboratory of Dr. Francisco Bolívar, who in 1977 achieved for the first time worldwide the production of transgenic proteins through Genetic Engineering techniques. In 2015 he carries out research at the Genomic Sciences Center (CCG-UNAM) in the area of Synthetic Biology and Systems Biology, in collaboration with world leaders in Systems Biology at the University of California at San Diego (UCSD). In 2017 he started a Master Research (MRes) in Synthetic Biology at the University College London (UCL), In this postgraduate program, he develops and standardizes the concept of minimal genome; it uses tools of Systems Biology, Synthetic Biology and Synthetic Ecology for the understanding, development, and application of microbial consortiums in the production of compounds of industrial interest, also promotes and promotes the development and proper use of the achievements given by Synthetic Biology, highlighting the ethical, moral and humanitarian aspects in its importance in the global regulation and rational use in humans. He is currently CEO & Founder of the Synbiomics Group, a corporate that brings together Startup’s (many of which he has founded and directed), Spin-offs and companies of the Biotechnological branch, Whose Investigations are focused on STEM sciences (SCIENCE, TECHNOLOGY, ENGINEERING, AND MATHEMATICS). He was recently named as one of the Young Leaders in Biotechnology in the LATAM region.
Synthetic Biology, Systems Biology, Synthetic Ecology, Genetic Engineering, Metabolic Engineering, Biofuels, Drug Discovery, Food Tech, Pharmaceuticals, Omic’s Sciences, Medicine, Precision Health, Preventive and Personalized Medicine.
Professor Srivastava, born in 1942, submitted his Ph.D. thesis in 1966 at Allahabad University and joined Haryana Agricultural University in 1967 and worked as Extension Plant Pathologist, Professor & Head Plant Pathology, & Director Planning and superannuated in Nov 2002. He is a distinguished scientist with over 50 years of experience, He is a legend whose drive and motivation coupled with innovation has inspired many stakeholders to follow him. He is considered as an architect of Extension Plant Pathology and known for his innovative periodicals and communication in the transfer of technology with greater emphasis on diagnostics and advisory for preventing losses due to plant pests and boosting productivity through efficient pest management and biotechnology. He is the first Indian Scientist to deliver a Keynote Address at 9th International Congress of Plant Pathology held at Christchurch, New Zealand in 2003 to cover these aspects. He is also the first scientist who was awarded Best Extension Scientist Award from Indian Council of Agricultural Research (ICAR) in 1996 for the triennium 1993-95, He is also recipient of several Honors and awards which include Fellowship of the National Academy of Sciences in 1988, Indian Phytopathological Recognition Award 2014, Life-Time Achievement Award in Plant Protection 2015, International Technological Achievement Award 2015 Scroll of Honor Award 2016 amongst others. He has played a pivotal role in the popularization of plant clinic by delivering lectures in India and abroad covering over a dozen countries. The two international giants – International Congress of Plant Pathology and International Plant Protection Congress have honored him to deliver keynote addresses, Session Organizers/chair speaks volume. .He has published over two hundred research papers several bulletins/books, periodicals like Plant Pathology Courier & Plant Disease Warning. He has been President of Indian Society of Plant Pathologist of India guided over a dozen students for their MS & Ph.D. Even after his superannuation in 2002, he is providing online diagnostic and advisory support free of cost through www.xsgrowth.com
Agriculture, Plant Pathology, Horticulture
Giulio Tarro graduated from Medicine School, Naples University (1962), Italy. Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus (2006). Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President, Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation, and characterization of specific virus-induced tumor antigens, which were the "fingerprints" left behind in human cancer. Achievements include patents in a field; a discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor-associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Prof. Hanan I. Malkawi is currently the Vice-President for Science Engagement at Royal Scientific Society (Amman-Jordan). She earned her bachelor degree in Biological Sciences at Yarmouk University (YU)-Jordan, and then she was offered a scholarship from YU to get her M.Sc in Bacteriology & Public and then doctorate degree in Microbiology & Molecular Biology both at Washington State University- USA, after which she returned to Jordan and appointed as professor at Yarmouk University. She has been heavily involved in research lines in biotechnology and bio-nanotechnology and their applications in environment, health, agriculture, microbiology, food & industry. She has been also involved in several projects in education and higher education and linking academia with industry. She has several funded grants from national & international agencies. She serves as the European Commission’s Higher Education Reform Expert (HEREs), for Jordan. Prof. Hanan is known for her devoted efforts in helping and inspiring young Jordanian scientists, and entrepreneurs, especially women, to pursue their graduate studies and research and build a career by assisting them with advice, mentorship, and coaching and providing them with guidance and feedback about how to start a business concept, and commercializing their research products, engaging them with society and introducing them to people and organizations. She registered several patents and has over 70 published papers in peer-reviewed international scientific journals and outstanding teaching and supervision activities at both the undergraduate and graduate levels. She has & still been invited as an invited speaker and member of the organizing committees in numerous International Congresses, Symposia and Forums and participated and gave talks in more than 90 conferences and workshops worldwide. She received several awards and fellowships and is an active member of several national, regional and international committees, associations & organizations. Prof. Malkawi has held several administrative positions: Vice President for Research & Int. Relations at YU, Dean of Scientific Research & Graduate Studies, Director of UNESCO Chair for Desert Studies, Director of Foreign Projects Management Unit, Director of Center of Excellence for Jordanian Public University Libraries, Vice-Dean of Faculty of Sciences, The Dean for Research & Doctoral studies at “Hamdan Bin Mohammad Smart University”, Dubai- UAE, where she gained an excellent experience in e-learning environment, smart excellence education and smart applications
Biotechnology, Bacteriology, Microbiology, Molecular Biology, Bionanotechnology, environmental and agricultural science
Dr Minaketan Tripathy was born in the village Padmabati, State Odisha, India, in 1978. He obtained his bachelor, master (Pharmaceutics) and doctoral degrees in the field of Pharmacy in the year of 1998, 2001, and 2006 respectively. After serving different institutes in India, Mina joined the faculty of Pharmacy, Universiti Teknologi MARA, Malaysia as a senior lecturer in March 2008 and established the laboratory of Fundamental of Pharmaceutics. Mina believes in trans-disciplinary research and interdisciplinary linkage. The laboratory attracted many research grants, engaged with supervision of research students and published several scientific articles in journals of repute and as well conference proceedings.
Biotechnology, Bacteriology, Microbiology, Molecular Biology, Bionanotechnology, environmental and agricultural science
Prof. Dr. C.P Abdolrasoul Aleezaadeh completed his Post Doctorate in (Psychology) at Approach of Applied Clinical Cognitive Neuropsychology from the USA. Prof. Dr. Aleezaadeh Completed his Ph.D. Degrees in Psychology at the USA. He completed his Master's Degree in Clinical Psychology at I. R. of the IRAN and Bachelor's Degree in General Psychology at I. R. of the IRAN. He is Full Expert International Faculty Professorship Member in the Brooklyn Central University, the USA, Associate Expert International Faculty Professorship Member in the University of Pacific Albion, the USA and, Associate Expert International Faculty Professorship Member in the Green Lake (GreenLake) University, the USA. Now he is working as an Assistant Professor at P.N.U and, U.A.S.T Universities; I.R. of IRAN.
Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.
Dr. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.